CAS: 937270-47-8; 6-Methyl-12-Oxa-3,6-Diaza-2(4,2)-Pyrimidina-1,4(1,3)-Dibenzenacyclododecaphan-8-Ene

该化合物是一种依赖环球的性血管抑制剂,有可能应用于肿瘤研究,特别是针对血浆瘤和其他恶性肿瘤的研究,该复合物显示出CDK2和CDK9的双重抑制作用,它扰乱细胞循环的进化和转录调节,这可能有助于其直肠效应.它的(E/Z)异构形式使得临床前研究具有更广泛的调查灵活性.关键优势包括它能够跨越血液脑屏障,成为...

结构式图片

合成工艺路线路线简述

  • 937271-61-9 = 937270-47-8
    反应条件:1.1 Reagents: Trifluoroacetic Acid Catalysts: Grubbs Second Generation Catalyst
    标题:Preparation Of Solid State Forms Of Macrocyclic Kinase Inhibitors For Treatment Of Cancers
    参考文献:World Intellectual Property Organization]

    937271-61-9 = 937270-47-8
    反应条件:1.1 Reagents: Trifluoroacetic Acid Catalysts: Grubbs Second Generation Catalyst Solvents: Dichloromethane; Rt; Overnight,50 °C
    标题:Preparation Of Heteroalkyl Linked Pyrimidine Macrocycle Derivatives As Antiproliferative Agents
    参考文献:World Intellectual Property Organization]

    = 937270-47-8 [标题:Reaction Conditions
    标题:Preparation Of The Prodrug Compound And Their Medical Applications
    参考文献:World Intellectual Property Organization]

    = 937270-47-8 [标题:Reaction Conditions
    标题:A Process For Obtaining Purified Unsaturated Macrocyclic Compounds
    参考文献:World Intellectual Property Organization

海关参考信息

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Pallis M, Abdul-Aziz A, Burrows F, Seedhouse C, Grundy M, Russell N. The multi-kinase inhibitor TG02 overcomes signalling activation by survival factors to deplete MCL1 and XIAP and induce cell death in primary acute myeloid leukaemia cells. Br J Haematol. 2012 Oct;159(2):191-203. doi: 10.1111/bjh.12018. Epub 2012 Aug 30. doi: 10.1007/s00894-012-1528-7. Epub 2012 Jul 22. doi: 10.1021/jm201112g. Epub 2011 Dec 29. doi: 10.1038/leu.2011.218. Epub 2011 Aug 23.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知